EMPROS PHARMA AB
2Patents
2Active
2Granted
39Portfolio score
Filing activity: Dec 17, 2015 → Jan 24, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11975105B2 | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | Human Necessities | 0 | Active |
| US10561617B2 | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.